Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (41-50 of 753) with videos related to

Pageof 76
Sort By:
Journal of the National Cancer Institute. Monographs|November 2, 2011
The triple-negative subtype: new ideas for the poorest prognosis breast cancerGiuseppe Curigliano, Aron Goldhirsch
Nature Clinical Practice. Oncology|July 12, 2007
To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancerGiuseppe Curigliano, Aron Goldhirsch
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Effects of friction and disorder on the quasistatic response of granular solids to a localized forceC Goldenberg, I Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
De-escalation attempts for adjuvant trastuzumab: longer beats shorterG Curigliano, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Old and new trends in the adjuvant treatment of early breast cancerA Goldhirsch, P Valagussa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IVA Goldhirsch, R D Gelber
Journal of the National Cancer Institute|May 4, 1994
Radiotherapy to the conserved breast: is it avoidable if the cancer is small?R D Gelber, A Goldhirsch
International Journal of Technology Assessment in Health Care|December 10, 1988
Comparison of adjuvant therapies using quality-of-life considerationsR D Gelber, A Goldhirsch
Journal of Surgical Oncology|December 29, 2006
Comparing aromatase inhibitors in the absence of clinical trial results can be misleadingAron Goldhirsch, Karen N Price
Archives of Gynecology and Obstetrics|October 4, 2016
A Goldhirsch, M Castiglione-Gertsch
Pageof 76

Showing results (41-50 of 753) with videos related to

Sort By:
Pageof 76
Journal of the National Cancer Institute. Monographs|November 2, 2011
The triple-negative subtype: new ideas for the poorest prognosis breast cancerGiuseppe Curigliano, Aron Goldhirsch
Nature Clinical Practice. Oncology|July 12, 2007
To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancerGiuseppe Curigliano, Aron Goldhirsch
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Effects of friction and disorder on the quasistatic response of granular solids to a localized forceC Goldenberg, I Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
De-escalation attempts for adjuvant trastuzumab: longer beats shorterG Curigliano, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Old and new trends in the adjuvant treatment of early breast cancerA Goldhirsch, P Valagussa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IVA Goldhirsch, R D Gelber
Journal of the National Cancer Institute|May 4, 1994
Radiotherapy to the conserved breast: is it avoidable if the cancer is small?R D Gelber, A Goldhirsch
International Journal of Technology Assessment in Health Care|December 10, 1988
Comparison of adjuvant therapies using quality-of-life considerationsR D Gelber, A Goldhirsch
Journal of Surgical Oncology|December 29, 2006
Comparing aromatase inhibitors in the absence of clinical trial results can be misleadingAron Goldhirsch, Karen N Price
Archives of Gynecology and Obstetrics|October 4, 2016
A Goldhirsch, M Castiglione-Gertsch
Pageof 76